{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:21:02Z","timestamp":1793467262093,"version":"4.5.0"},"reference-count":104,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>Meningiomas are the most common primary intracranial neoplasms in adults. Current histopathological grading schemes do not consistently predict their natural history. Classic cytogenetic studies have disclosed a progressive course of chromosomal aberrations, especially in high-grade meningiomas. Furthermore, the recent application of unbiased next-generation sequencing approaches has implicated several novel genes whose mutations underlie a substantial percentage of meningiomas. These insights may serve to craft a molecular taxonomy for meningiomas and highlight putative therapeutic targets in a new era of rational biology-informed precision medicine.<\/jats:p>","DOI":"10.3171\/2015.6.jns15591","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T19:49:00Z","timestamp":1452887340000},"page":"525-535","source":"Crossref","is-referenced-by-count":103,"title":["Genomic landscape of intracranial meningiomas"],"prefix":"10.3171","volume":"125","author":[{"given":"Wenya Linda","family":"Bi","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women's Hospital;"},{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Abedalthagafi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Neuropathology, Brigham and Women's Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peleg","family":"Horowitz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women's Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj K.","family":"Agarwalla","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Massachusetts General Hospital;"},{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women's Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayal A.","family":"Aizer","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Brewster","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Neuropathology, Brigham and Women's Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin P.","family":"Dunn","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Pathology, and Immunology, Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ossama","family":"Al-Mefty","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women's Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Santagata","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Neuropathology, Brigham and Women's Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rameen","family":"Beroukhim","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F.","family":"Dunn","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brigham and Women's Hospital;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns15591","series-title":"Am J Hum Genet","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ajhg.2012.07.015","article-title":"Loss of SUFU function in familial multiple meningioma","volume":"91","author":"Aavikko","year":"2012"},{"key":"b2-jns15591","series-title":"Oncotarget","doi-asserted-by":"publisher","first-page":"10596","DOI":"10.18632\/oncotarget.2517","article-title":"Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5","volume":"5","author":"Abedalthagafi","year":"2014"},{"key":"b3-jns15591","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3171\/jns.2004.101.2.0210","article-title":"Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings","volume":"101","author":"Al-Mefty","year":"2004"},{"key":"b4-jns15591","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3171\/jns.2004.100.6.1002","article-title":"Radiation-induced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics","volume":"100","author":"Al-Mefty","year":"2004"},{"key":"b5-jns15591","series-title":"Neurogenetics","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10048-009-0204-2","article-title":"Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation","volume":"11","author":"Bacci","year":"2010"},{"key":"b6-jns15591","series-title":"Int J Clin Exp Pathol","first-page":"231","article-title":"The histopathological spectrum of human meningiomas","volume":"5","author":"Backer-Gr\u00f8ndahl","year":"2012"},{"key":"b7-jns15591","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1054\/bjoc.1999.1030","article-title":"Neurofibromatosis 2, radiosurgery and malignant nervous system tumours","volume":"82","author":"Baser","year":"2000"},{"key":"b8-jns15591","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00401-004-0911-6","article-title":"DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q","volume":"108","author":"Bello","year":"2004"},{"key":"b9-jns15591","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1038\/onc.2008.170","article-title":"AKT1(E17K) in human solid tumours","volume":"27","author":"Bleeker","year":"2008"},{"key":"b10-jns15591","series-title":"Cancer Res","first-page":"29","article-title":"Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q","volume":"58","author":"Bostr\u00f6m","year":"1998"},{"key":"b11-jns15591","series-title":"Am J Pathol","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","article-title":"Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas","volume":"159","author":"Bostr\u00f6m","year":"2001"},{"key":"b12-jns15591","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"Brastianos","year":"2013"},{"key":"b13-jns15591","series-title":"Cell","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013"},{"key":"b14-jns15591","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ijc.1219","article-title":"Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM-1 and DCC tumor suppressor genes on the long arm of chromosome 18","volume":"92","author":"B\u00fcschges","year":"2001"},{"key":"b15-jns15591","series-title":"Brain Pathol","first-page":"145","article-title":"Allelic gain and amplification on the long arm of chromosome 17 in anaplastic meningiomas","volume":"12","author":"B\u00fcschges","year":"2002"},{"key":"b16-jns15591","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/jnen\/60.6.628","article-title":"Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications","volume":"60","author":"Cai","year":"2001"},{"key":"b17-jns15591","series-title":"Mol Cancer","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1476-4598-6-64","article-title":"Molecular signatures define two main classes of meningiomas","volume":"6","author":"Carvalho","year":"2007"},{"key":"b18-jns15591","series-title":"Acta Radiol Suppl","first-page":"1","article-title":"Meningiomas of the posterior fossa","volume":"104","author":"Castellano","year":"1953"},{"key":"b19-jns15591","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1002\/1097-0142(20001115)89:10<2092::AID-CNCR9>3.0.CO;2-N","article-title":"Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas","volume":"89","author":"Chen","year":"2000"},{"key":"b20-jns15591","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1161\/STROKEAHA.108.527135","article-title":"Apoptotic functions of PDCD10\/CCM3, the gene mutated in cerebral cavernous malformation 3","volume":"40","author":"Chen","year":"2009"},{"key":"b21-jns15591","series-title":"J Med Genet","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/jmg.2010.082420","article-title":"Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas","volume":"48","author":"Christiaans","year":"2011"},{"key":"b22-jns15591","series-title":"Science","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013"},{"key":"b23-jns15591","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1158\/0008-5472.CAN-05-0240","article-title":"Meningioma transcript profiles reveal deregulated Notch signaling pathway","volume":"65","author":"Cuevas","year":"2005"},{"key":"b24-jns15591","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.bjc.6604002","article-title":"Nf2\/Merlin: a coordinator of receptor signalling and intercellular contact","volume":"98","author":"Curto","year":"2008"},{"key":"b25-jns15591","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1038\/onc.2013.261","article-title":"Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1\/Snf5-mediated tumorigenesis","volume":"33","author":"Darr","year":"2014"},{"key":"b26-jns15591","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001"},{"key":"b27-jns15591","series-title":"Oncotarget","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.18632\/oncotarget.3082","article-title":"Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma","volume":"6","author":"Du","year":"2015"},{"key":"b28-jns15591","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11060-009-9934-0","article-title":"WHO grade II and III meningiomas: a study of prognostic factors","volume":"95","author":"Durand","year":"2009"},{"key":"b29-jns15591","series-title":"Mol Cell Biol","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1128\/MCB.00444-06","article-title":"UV radiation induces delayed hyperrecombination associated with hypermutation in human cells","volume":"26","author":"Durant","year":"2006"},{"key":"b30-jns15591","series-title":"Ann N Y Acad Sci","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1749-6632.1991.tb37776.x","article-title":"Molecular genetics of neurofibromatosis 2 and related tumors (acoustic neuroma and meningioma)","volume":"615","author":"Fontaine","year":"1991"},{"key":"b31-jns15591","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bpa.12110","article-title":"High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression","volume":"24","author":"Goutagny","year":"2014"},{"key":"b32-jns15591","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1158\/1078-0432.CCR-10-0891","article-title":"Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status","volume":"16","author":"Goutagny","year":"2010"},{"key":"b33-jns15591","series-title":"J Med Genet","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/jmg.2009.075721","article-title":"SMARCB1 mutations are not a common cause of multiple meningiomas","volume":"47","author":"Hadfield","year":"2010"},{"key":"b34-jns15591","series-title":"Nat Cell Biol","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ncb1339","article-title":"The tumour-suppressor genes NF2\/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis","volume":"8","author":"Hamaratoglu","year":"2006"},{"key":"b35-jns15591","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3171\/jns.1996.84.5.0847","article-title":"Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma","volume":"84","author":"Harada","year":"1996"},{"key":"b36-jns15591","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1212\/01.WNL.0000138569.45818.50","article-title":"Natural history of conservatively treated meningiomas","volume":"63","author":"Herscovici","year":"2004"},{"key":"b37-jns15591","series-title":"Am J Surg Pathol","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1097\/PAS.0b013e31822b325b","article-title":"INI1-deficient tumors: diagnostic features and molecular genetics","volume":"35","author":"Hollmann","year":"2011"},{"key":"b38-jns15591","series-title":"Mol Cell Biol","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009"},{"key":"b39-jns15591","series-title":"Mol Cancer Res","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1158\/1541-7786.MCR-11-0425-T","article-title":"Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types","volume":"10","author":"James","year":"2012"},{"key":"b40-jns15591","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3171\/2009.7.JNS09726","article-title":"Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway","volume":"112","author":"Johnson","year":"2010"},{"key":"b41-jns15591","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1023\/B:NEON.0000013461.35120.8a","article-title":"Transforming growth factor-beta effects on meningioma cell proliferation and signal transduction pathways","volume":"66","author":"Johnson","year":"2004"},{"key":"b42-jns15591","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3171\/jns.2001.94.2.0293","article-title":"Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells","volume":"94","author":"Johnson","year":"2001"},{"key":"b43-jns15591","series-title":"Nature","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature11284","article-title":"Dissecting the genomic complexity underlying medulloblastoma","volume":"488","author":"Jones","year":"2012"},{"key":"b44-jns15591","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1101\/gad.226302","article-title":"Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse","volume":"16","author":"Kalamarides","year":"2002"},{"key":"b45-jns15591","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/onc.2010.609","article-title":"Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes","volume":"30","author":"Kalamarides","year":"2011"},{"key":"b46-jns15591","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/neuonc\/not330","article-title":"Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review","volume":"16","author":"Kaley","year":"2014"},{"key":"b47-jns15591","series-title":"J Pathol","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/path.909","article-title":"NF2 status of meningiomas is associated with tumour localization and histology","volume":"194","author":"Kros","year":"2001"},{"key":"b48-jns15591","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1212\/WNL.0b013e3181a92b13","article-title":"Multiple dural lesions mimicking meningiomas in patients with CCM3\/PDCD10 mutations","volume":"72","author":"Labauge","year":"2009"},{"key":"b49-jns15591","series-title":"Hum Pathol","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S0046-8177(97)90029-0","article-title":"Telomerase activity in ordinary meningiomas predicts poor outcome","volume":"28","author":"Langford","year":"1997"},{"key":"b50-jns15591","series-title":"Nature","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014"},{"key":"b51-jns15591","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3171\/jns.2004.100.2.0303","article-title":"Prognostic value of allelic losses and telomerase activity in meningiomas","volume":"100","author":"Leuraud","year":"2004"},{"key":"b52-jns15591","series-title":"Hum Pathol","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.humpath.2005.02.006","article-title":"Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas","volume":"36","author":"Liu","year":"2005"},{"key":"b53-jns15591","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0165-4608(03)00244-9","article-title":"Methylation status of TP73 in meningiomas","volume":"148","author":"Lomas","year":"2004"},{"key":"b54-jns15591","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0165-4608(01)00430-7","article-title":"Analysis of p73 gene in meningiomas with deletion at 1p","volume":"129","author":"Lomas","year":"2001"},{"key":"b55-jns15591","series-title":"WHO Classification of Tumours of the Central Nervous System","year":"2007"},{"key":"b56-jns15591","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1073\/pnas.1012617108","article-title":"Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology","volume":"108","author":"Louvi","year":"2011"},{"key":"b57-jns15591","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-05-0043","article-title":"Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma","volume":"65","author":"Lusis","year":"2005"},{"key":"b58-jns15591","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1158\/1078-0432.CCR-04-2550","article-title":"Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas","volume":"11","author":"Mawrin","year":"2005"},{"key":"b59-jns15591","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJMra0907178","article-title":"Genomics and the continuum of cancer care","volume":"364","author":"McDermott","year":"2011"},{"key":"b60-jns15591","series-title":"Mol Carcinog","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/(SICI)1098-2744(199904)24:4<300::AID-MC8>3.0.CO;2-G","article-title":"Search for mutations of the hRAD54 gene in sporadic meningiomas with deletion at 1p32","volume":"24","author":"Mendiola","year":"1999"},{"key":"b61-jns15591","series-title":"Genes Chromosomes Cancer","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/gcc.2870130311","article-title":"Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas","volume":"13","author":"M\u00e9rel","year":"1995"},{"key":"b62-jns15591","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1158\/0008-5472.CAN-06-1608","article-title":"Merlin\/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac","volume":"67","author":"Morrison","year":"2007"},{"key":"b63-jns15591","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/00005072-199708000-00006","article-title":"Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1","volume":"56","author":"Niedermayer","year":"1997"},{"key":"b64-jns15591","series-title":"Nat Rev Neurol","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nrneurol.2012.78","article-title":"The clinical implications of medulloblastoma subgroups","volume":"8","author":"Northcott","year":"2012"},{"issue":"Suppl 2","key":"b65-jns15591","series-title":"Neuro Oncol","first-page":"ii1","article-title":"CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010","volume":"15","author":"Ostrom","year":"2013"},{"issue":"4","key":"b66-jns15591","series-title":"Neurosurg Focus","first-page":"e3","article-title":"Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases","volume":"2","author":"Palma","year":"1997"},{"key":"b67-jns15591","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3171\/jns.1997.86.5.0793","article-title":"Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases","volume":"86","author":"Palma","year":"1997"},{"key":"b68-jns15591","series-title":"Brain Pathol","first-page":"183","article-title":"A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas","volume":"12","author":"Perry","year":"2002"},{"key":"b69-jns15591","series-title":"WHO Classification of Tumours of the Central Nervous System","first-page":"164","article-title":"Meningiomas","author":"Perry","year":"2007"},{"key":"b70-jns15591","series-title":"Cancer","first-page":"2046","article-title":"\u201cMalignancy\u201d in meningiomas: a clinicopathologic study of 116 patients, with grading implications","volume":"85","author":"Perry","year":"1999"},{"key":"b71-jns15591","series-title":"Neuropathol Appl Neurobiol","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1365-2990.1998.00093.x","article-title":"Analysis of the PTEN gene in human meningiomas","volume":"24","author":"Peters","year":"1998"},{"key":"b72-jns15591","series-title":"Cancer Genet Cytogenet","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cancergencyto.2005.02.009","article-title":"GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis","volume":"162","author":"Piaskowski","year":"2005"},{"key":"b73-jns15591","series-title":"Cancer Res","first-page":"1798","article-title":"Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system","volume":"58","author":"Reifenberger","year":"1998"},{"key":"b74-jns15591","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","article-title":"Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations","volume":"125","author":"Reuss","year":"2013"},{"key":"b75-jns15591","series-title":"Mol Syndromol","first-page":"165","article-title":"CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas","volume":"4","author":"Riant","year":"2013"},{"key":"b76-jns15591","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","article-title":"Histological classification and molecular genetics of meningiomas","volume":"5","author":"Riemenschneider","year":"2006"},{"key":"b77-jns15591","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","article-title":"Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review","volume":"122","author":"Rogers","year":"2015"},{"key":"b78-jns15591","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"18200","DOI":"10.1073\/pnas.0405971102","article-title":"Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L","volume":"101","author":"Rong","year":"2004"},{"key":"b79-jns15591","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0294-180","article-title":"Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas","volume":"6","author":"Ruttledge","year":"1994"},{"key":"b80-jns15591","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00401-013-1187-5","article-title":"AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry","volume":"126","author":"Sahm","year":"2013"},{"key":"b81-jns15591","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<440::AID-CNCR27>3.0.CO;2-5","article-title":"A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients","volume":"88","author":"Sawyer","year":"2000"},{"key":"b82-jns15591","series-title":"Br J Cancer","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1054\/bjoc.2000.1583","article-title":"INI1 mutations in meningiomas at a potential hotspot in exon 9","volume":"84","author":"Schmitz","year":"2001"},{"key":"b83-jns15591","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic","year":"2012"},{"key":"b84-jns15591","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1227\/01.NEU.0000255421.78431.AE","article-title":"Molecular genetics of meningiomas: from basic research to potential clinical applications","volume":"60","author":"Simon","year":"2007"},{"key":"b85-jns15591","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3171\/jns.2000.92.5.0832","article-title":"Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression","volume":"92","author":"Simon","year":"2000"},{"key":"b86-jns15591","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"20","author":"Simpson","year":"1957"},{"key":"b87-jns15591","series-title":"Nat Genet","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ng.2552","article-title":"Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas","volume":"45","author":"Smith","year":"2013"},{"key":"b88-jns15591","series-title":"J Pathol","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/path.4427","article-title":"Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas","volume":"234","author":"Smith","year":"2014"},{"key":"b89-jns15591","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012"},{"key":"b90-jns15591","series-title":"Genes Chromosomes Cancer","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<270::AID-GCC14>3.0.CO;2-W","article-title":"Unbalanced translocation t(1;3)(p12-13;q11) in meningiomas as the unique feature of chordoid differentiation","volume":"26","author":"Steilen-Gimbel","year":"1999"},{"key":"b91-jns15591","series-title":"EMBO J","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","article-title":"The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2","volume":"17","author":"Stott","year":"1998"},{"key":"b92-jns15591","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1227\/NEU.0000000000000462","article-title":"Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection","volume":"75","author":"Sun","year":"2014"},{"key":"b93-jns15591","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1227\/NEU.0000000000000461","article-title":"Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection","volume":"75","author":"Sun","year":"2014"},{"key":"b94-jns15591","series-title":"Cell","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007"},{"key":"b95-jns15591","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ijrobp.2009.11.032","article-title":"Outcomes of WHO Grade I meningiomas receiving definitive or postoperative radiotherapy","volume":"79","author":"Tanzler","year":"2011"},{"key":"b96-jns15591","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/neuonc\/nos013","article-title":"Impaired survival and long-term neurological problems in benign meningioma","volume":"14","author":"van Alkemade","year":"2012"},{"key":"b97-jns15591","series-title":"Neurogenetics","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10048-011-0300-y","article-title":"Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri","volume":"13","author":"van den Munckhof","year":"2012"},{"key":"b98-jns15591","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1056\/NEJMoa070972","article-title":"Incidental findings on brain MRI in the general population","volume":"357","author":"Vernooij","year":"2007"},{"key":"b99-jns15591","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","article-title":"Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression","volume":"94","author":"Weber","year":"1997"},{"key":"b100-jns15591","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11060-010-0349-8","article-title":"Medical therapies for meningiomas","volume":"99","author":"Wen","year":"2010"},{"key":"b101-jns15591","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2011.07.007","article-title":"Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma","volume":"20","author":"Witt","year":"2011"},{"key":"b102-jns15591","series-title":"Neoplasia","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1593\/neo.111574","article-title":"Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma","volume":"14","author":"Yang","year":"2012"},{"key":"b103-jns15591","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1136\/jnnp.2007.121582","article-title":"Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features","volume":"79","author":"Yang","year":"2008"},{"key":"b104-jns15591","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","article-title":"Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression","volume":"70","author":"Zhang","year":"2010"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/125\/3\/article-p525.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/125\/3\/article-p525.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/125\/3\/article-p525.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T19:54:30Z","timestamp":1682798070000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/125\/3\/article-p525.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":104,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2015.6.jns15591","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726077463.793544874","asserted-by":"object"}]},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}